RECURRENT HEPATOBLASTOMA
Clinical trials for RECURRENT HEPATOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT HEPATOBLASTOMA trials appear
Sign up with your email to follow new studies for RECURRENT HEPATOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with tough cancers: experimental drug trial opens
Disease control Recruiting nowThis study is testing a new drug called tegavivint in children, teens, and young adults whose solid tumors or lymphomas have come back or haven't responded to other treatments. The main goals are to find the safest dose, understand the side effects, and see if the drug can help s…
Matched conditions: RECURRENT HEPATOBLASTOMA
Phase: PHASE1, PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
New hope for kids with tough cancers: trial tests Double-Team drug strategy
Disease control Recruiting nowThis study is testing two different drug combinations to find safe doses and see if they can help control cancer in children and young adults whose solid tumors have come back or haven't responded to treatment. In the first part, participants will be assigned to receive either On…
Matched conditions: RECURRENT HEPATOBLASTOMA
Phase: PHASE1, PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Mar 02, 2026 15:24 UTC